93 related articles for article (PubMed ID: 6165205)
41. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
[TBL] [Abstract][Full Text] [Related]
42. Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthma.
Willey RF; Godden DJ; Carmichael J; Preston P; Frame M; Crompton GK
Br J Dis Chest; 1982 Jan; 76(1):61-8. PubMed ID: 7037035
[TBL] [Abstract][Full Text] [Related]
43. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
[No Abstract] [Full Text] [Related]
44. Effects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasis.
de Jong EM; Ferrier CM; de Zwart A; Wauben-Penris PJ; Korstanje C; van de Kerkhof PC
J Dermatol Sci; 1995 May; 9(3):185-94. PubMed ID: 8664216
[TBL] [Abstract][Full Text] [Related]
45. A dimethoxynaphthalene derivative (RS-43179 gel) compared with 0.025% fluocinolone acetonide gel in the treatment of psoriasis.
Lassus A; Forsstrom S
Br J Dermatol; 1985 Jul; 113(1):103-6. PubMed ID: 3893513
[TBL] [Abstract][Full Text] [Related]
46. A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis.
Danielsson A; Hellers G; Lyrenäs E; Löfberg R; Nilsson A; Olsson O; Olsson SA; Persson T; Salde L; Naesdal J
Scand J Gastroenterol; 1987 Oct; 22(8):987-92. PubMed ID: 3317784
[TBL] [Abstract][Full Text] [Related]
47. A double-blind comparison of a new combination (halcinonide-neomycin-amphotericin) and active controls in cutaneous candidiasis and steroid-responsive dermatoses.
Abdel-Aal H; Abdel-Fattah A; Shiemy S; Faris R; Tadros SS
J Int Med Res; 1976; 4(4):232-6. PubMed ID: 799995
[TBL] [Abstract][Full Text] [Related]
48. Comparison of topical fluocinolone and tumenol prednisolone: a double-blind trial.
Stahle IO; Webb JG
Med J Aust; 1965 Sep; 2(10):418-20. PubMed ID: 5318272
[No Abstract] [Full Text] [Related]
49. Synthesis and anti-inflammatory properties of budesonide, a new non-halogenated glucocorticoid with high local activity.
Thalén A; Brattsand R
Arzneimittelforschung; 1979; 29(11):1687-90. PubMed ID: 543875
[TBL] [Abstract][Full Text] [Related]
50. Correlation of the vasoconstriction assay and clinical activity in psoriasis.
Cornell RC; Stoughton RB
Arch Dermatol; 1985 Jan; 121(1):63-7. PubMed ID: 3881088
[TBL] [Abstract][Full Text] [Related]
51. A multicentre trial of "metosyn"--a new topical steroid in a complex two phase base.
Nicholls JT
Curr Ther Res Clin Exp; 1972 May; 14(5):259-63. PubMed ID: 4623977
[No Abstract] [Full Text] [Related]
52. A comparative clinical evaluation of a new topical steroid 'halcinonide' and hydrocortisone in steroid-responsive dermatoses.
Fattah AA; El-Shiemy S; Faris R; Tadros SS
J Int Med Res; 1976; 4(4):228-31. PubMed ID: 1026547
[TBL] [Abstract][Full Text] [Related]
53. [A double-blind clinical trial of fluocinonide and betamethasone valerate in psoriasis].
Feuerman E
Harefuah; 1974 Jul; 87(2):59-60. PubMed ID: 4605470
[No Abstract] [Full Text] [Related]
54. [Treatment of psoriasis with Synalar ointment].
Chowaniec O
Przegl Dermatol; 1973; 60(2):234-8. PubMed ID: 4791679
[No Abstract] [Full Text] [Related]
55. A comparative study of amcinonide and halcinonide 0.1% ointments in the treatment of psoriasis.
Millikan LE; Mroczkowski TF
Int J Dermatol; 1986 Oct; 25(8):542. PubMed ID: 3533806
[No Abstract] [Full Text] [Related]
56. Contact allergy to the corticosteroid budesonide.
van Hecke E; Temmerman L
Contact Dermatitis; 1980 Dec; 6(7):509. PubMed ID: 7214905
[No Abstract] [Full Text] [Related]
57. Diphenoxylate therapy for psoriasis.
Lanier EW
Arch Dermatol; 1985 Dec; 121(12):1486. PubMed ID: 3904635
[No Abstract] [Full Text] [Related]
58. Clinical evaluation of tralonide ointment, a new topical steroid.
Cullen SI
Curr Ther Res Clin Exp; 1971 Sep; 13(9):595-601. PubMed ID: 5000463
[No Abstract] [Full Text] [Related]
59. [Results of treatment with synalar ointment].
Koźmińska A; Pawlowski A
Przegl Dermatol; 1966; 53(2):193-6. PubMed ID: 5943977
[No Abstract] [Full Text] [Related]
60. Weekly pulse dosing schedule of fluorouracil: a new topical therapy for psoriasis.
Pearlman DL; Youngberg B; Engelhard C
J Am Acad Dermatol; 1986 Dec; 15(6):1247-52. PubMed ID: 3543072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
